Rabies and rabies immunobiological preparations: vaccinations Pasteur to the contemporary biotechnology

Author:

Abramova E. G.1,Nikiforov A. K.2,Movsesyants A. A.3,Zhulidov I. M.1

Affiliation:

1. Russian Research Institute for Plague Control «Microb»

2. Russian Research Institute for Plague Control «Microb»; Vavilov Saratov State Agrarian University

3. Scientific Centre for Expert Evaluation of Medicinal Products

Abstract

The review provides information on topical issues of rabies spread in the world and the Russian Federation, the stages of development and directions of improvement of available preventive anti-rabies immunobiological preparation used in medical practice for active and passive immunization against rabies. The current level of biotechnology development with the use of molecular biology and genetic engineering methods opens up prospects for the design of new safe effective anti-rabies drugs using recombinant technologies. Expanding the range of immunobiological drugs against rabies and their introduction into health practice will contribute to the elimination of human mortality from rabies.

Publisher

Central Research Institute for Epidemiology

Subject

General Medicine

Reference50 articles.

1. Abramova E.G., Generalov S.V., Matveeva Zh.V., Zhulidov I.M., Nikiforov A.K., Komissarov A.V. Eksperimental'noe obosnovanie vnedreniya kul'tural'nykh tekhnologii v proizvodstvo antirabicheskogo immunoglobulina. Problemy osobo opasnykh infektsii. 2016, 2: 95-102.

2. Benevolenskii S.V., Zatsepin S.S., Klyachko E.V., Morozkina E.V., Pozdnyakova L. P., Sveshnikov P.G., Solopova O. N., Shemchukova O.B., Yagudin T.A. Gumanizirovannye antigensvyazyvayushchie fragmenty (fab) protiv virusa beshenstva, izolirovannyi fragment dnk, kodiruyushchii fab protiv virusa beshenstva, kletka drozhzhei, transformirovannaya fragmentom dnk, i sposob polucheniya fab protiv virusa beshenstva s ispol'zovaniem drozhzhei. Patent RF № 2440412, MPK C12N001/00. 25.03.2010.

3. Generalov S.V., Abramova E.G., Matveeva Zh.V., Zhulidov I.M., Nikiforov A.K., Lobovikova O.A., Svintsov R.A., Razzhivin A.V., Savitskaya L.V., Galkina M.V., Mikheeva T.A., Komissarov A.V., Kireev M.N. Kul'tural'nyi antigen v tekhnologii polucheniya antirabicheskogo immunoglobulina iz syvorotki krovi loshadi. Problemy osobo opasnykh infektsii. 2012, 4 (114): 65-68.

4. Generalov S.V., Abramova E.G., Nikiforov A.K., Savitskaya L.V., Galkina M.V., Minaeva L.N., Mikheeva T.A., Selezneva A.G., Zhulidov I.M., Svintsov R.A., Lazarenko G.P., Brandzishevskii Yu.V. Izuchenie anafilaktogennykh svoistv F(ab’)2-fragmentov geterologichnogo antirabicheskogo immunoglobulina. Problemy osobo opasnykh infektsii. 2009, 2: 65-67.

5. Gorbacheva P., Makarov V.V. Rekombinantnaya antirabicheskaya vaktsina dlya oral'noi immunizatsii lisits. Veterinarnaya patologiya. 2010, 2: 16-18.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3